WS #16405

The dominant market narrative remains anchored by escalating Middle East tensions, with Brent crude surging above $117 and market probability models pricing in a 34% chance of oil exceeding $110 by month-end. This supply-risk thesis is intensifying as Rosneft reports that Ukrainian drone strikes and sanctions are threatening its survival, creating a dual-threat of physical supply disruption and financial insolvency for a major global producer. While a ceasefire poll remains active, the physical market data and geopolitical friction are driving a clear bearish signal for energy consumers (airlines, shipping) and a bullish signal for energy producers and refiners. In a significant structural shift, the US government has designated helium as a critical material for semiconductors. This policy intervention supports the domestic supply chain thesis for semiconductor equipment and gas providers, acting as a counter-signal to broader macro fears regarding trade wars or export restrictions. Concurrently, the tech sector is seeing a bifurcation: while AI agent startups like Daytona hit $1B valuations, established players face specific headwinds, including Alphabet's Gemini 4 Argon launch facing stiff competition from ChatGPT and SpaceX's tower lease negotiations pressuring telecom REITs. The biotech sector experienced a sharp, isolated correction with Moderna plunging 18% on disappointing melanoma vaccine data, though clinical experts maintain the underlying technology is a major advancement. This highlights a growing disconnect between binary clinical trial outcomes and long-term therapeutic potential. Meanwhile, corporate activity is focused on defensive maneuvers and M&A, with Blackstone leading a $300M buyout of Gooch & Housego and Debenhams reporting a rare profit turnaround.